Vimarsana
Biggest News Aggregation in the World

Page 9 - Forefront Analytics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Forefront Analytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Forefront Analytics Today - Breaking & Trending Today

ALX Oncology (NASDAQ:ALXO) Stock Price Down 4.8% - Vimarsana News

ALX Oncology (NASDAQ:ALXO) Stock Price Down 4.8%

Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) dropped 4.8% on Monday . The stock traded as low as $14.85 and last traded at $14.85. 92,072 shares traded hands during trading, a decline of 79% from the average daily volume of 430,712 shares. The stock had previously closed at $15.60. Analyst Ratings […]

Annexon (NASDAQ:ANNX) Given Buy Rating at Needham & Company LLC - Vimarsana News

Annexon (NASDAQ:ANNX) Given Buy Rating at Needham & Company LLC

Annexon (NASDAQ:ANNX – Get Free Report)‘s stock had its “buy” rating reissued by Needham & Company LLC in a research report issued on Thursday, Benzinga reports. They presently have a $16.00 price target on the stock. Needham & Company LLC’s target price would indicate a potential upside of 167.56% from the stock’s current price. Several […]

Annexon, Inc. (NASDAQ:ANNX) Receives $13.57 Consensus PT from Analysts - Vimarsana News

Annexon, Inc. (NASDAQ:ANNX) Receives $13.57 Consensus PT from Analysts

Annexon, Inc. (NASDAQ:ANNX – Get Free Report) has been assigned an average recommendation of “Buy” from the six research firms that are presently covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have issued a report on the […]

Short Interest in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Declines By 8.3% - Vimarsana News

Short Interest in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Declines By 8.3%

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 7,920,000 shares, a drop of 8.3% from the February 29th total of 8,640,000 shares. Based on an average trading volume of 2,210,000 shares, […]

Zura Bio (NASDAQ:ZURA) Rating Reiterated by Oppenheimer - Vimarsana News

Zura Bio (NASDAQ:ZURA) Rating Reiterated by Oppenheimer

Zura Bio (NASDAQ:ZURA – Get Free Report)‘s stock had its “outperform” rating reiterated by equities research analysts at Oppenheimer in a research note issued to investors on Monday, Benzinga reports. They presently have a $16.00 price objective on the stock, down from their previous price objective of $17.00. Zura Bio Stock Up 0.4 % NASDAQ:ZURA […]

Source: wkrb13.com